The University City Science Center has announced three awardees in the latest round of its QED Proof-of-Concept Program, which partners with regional academic and research institutions to prepare their most promising life science technologies for commercialization. 

The three researchers, representing the Children’s Hospital of Philadelphia, the University of Delaware and the University of Pennsylvania, are developing a new therapy for acute leukemia using an agent that jump-starts the immune system; nanoparticles that deliver therapeutic cargo to stem cells; and an improved method for diagnosing and detecting cancer in liquid biopsies. 

READ MORE